Your browser doesn't support javascript.
loading
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis.
Hermann, Robert; Karlsson, Mats O; Novakovic, Ana M; Terranova, Nadia; Fluck, Markus; Munafo, Alain.
Afiliação
  • Hermann R; Clinical Research Appliance (Cr Appliance), Heinrich-Vingerhut-Weg 3, 63571, Gelnhausen, Germany. robert.hermann@cr-appliance.com.
  • Karlsson MO; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Novakovic AM; Merck KGaA, Darmstadt, Germany.
  • Terranova N; Merck Institute for Pharmacometrics, Merck Serono S.A., Switzerland, an Affiliate of Merck KGaA, Darmstadt, Germany.
  • Fluck M; Merck KGaA, Darmstadt, Germany.
  • Munafo A; Merck Institute for Pharmacometrics, Merck Serono S.A., Switzerland, an Affiliate of Merck KGaA, Darmstadt, Germany.
Clin Pharmacokinet ; 58(3): 401, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30066294
ABSTRACT
The cladribine prodrug is phosphorylated intracellularly to its active product, 2-chlorodeoxyadenosine triphosphate (Cd-ATP), by deoxycytidine kinase.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article